Choosing Oxytetracycline 10% Injection: Application Fit and Specification Checks

What Is Oxytetracycline 10% Injection?

Oxytetracycline 10 injection is a broad-spectrum antibiotic solution that delivers 100 mg of oxytetracycline per millilitre. As a tetracycline-class antibiotic, it works by inhibiting bacterial protein synthesis, producing a bacteriostatic effect against a wide range of Gram-positive and Gram-negative organisms. The injectable form bypasses the digestive tract, enabling rapid systemic absorption and faster onset of action compared with oral formulations—a practical advantage when treating acutely ill livestock.

Shijiazhuang Roc Cattle I&E Trading Co.,Ltd carries this formulation within its veterinary antibiotic line, positioned alongside the 5% and 20% L.A. variants to support different clinical and operational requirements.

Bacterial Coverage and Indications

The confirmed product description identifies the following susceptible organisms:

• Bordetella, Campylobacter, Chlamydia
• E. coli, Haemophilus, Mycoplasma
• Pasteurella, Rickettsia, Salmonella
• Staphylococcus and Streptococcus spp.

Approved indications include arthritis, gastrointestinal infections, and respiratory infections caused by oxytetracycline-sensitive micro-organisms. Urinary and soft tissue infections are described in the product summary, consistent with the broad systemic distribution of the molecule.

Approved animal species: calves, cattle, goats, sheep, and swine.

Note: Treatment should only be initiated when susceptibility of the causative organism to oxytetracycline has been confirmed or is clinically probable. A veterinarian should be consulted for diagnosis and dosage confirmation.

Dosage and Administration

The 10% formulation is administered intramuscularly or subcutaneously according to the following schedule:

Maximum volume per injection site:

• Cattle: 20 ml
• Swine: 10 ml
• Calves, goats, sheep: 5 ml

These site-volume limits are important for minimising local tissue reactions and ensuring adequate absorption. If a dose calculation exceeds the per-site maximum, multiple sites must be used.

Withdrawal Times

Buyers sourcing for operations with frequent slaughter or active milking cycles should factor these periods into their treatment scheduling before procurement.

Contraindications and Safety Checks

Before selecting oxytetracycline 10 injection, confirm the following conditions are not present:

1. Hypersensitivity to tetracyclines — animals with a known reaction history must not be treated.
2. Serious renal or liver impairment — oxytetracycline is primarily excreted via urine and partially via bile; compromised elimination increases toxicity risk.
3. Concurrent use of penicillins, cephalosporins, quinolones, or cycloserine — these drug classes are incompatible with oxytetracycline and must not be co-administered.

Potential side effects include local injection-site reactions (typically resolving within a few days), tooth discolouration in young animals, and hypersensitivity reactions.

How the 10% Formulation Compares with 5% and 20% L.A. Alternatives

Shijiazhuang Roc Cattle I&E Trading Co.,Ltd offers three oxytetracycline injection concentrations. The differences affect dosing volume, administration interval, species coverage, and withdrawal commitments.

Concentration and Active Content

Species Coverage

The 5% formulation's confirmed indications do not include cattle—it lists calves, goats, sheep, and swine only. The 10% and 20% L.A. formulations both cover calves, cattle, goats, sheep, and swine, making them appropriate for full cattle herd treatment programs.

Dosing Interval

The 10% formulation requires daily administration over 3–5 days. The 20% L.A. variant is explicitly described as long-acting: "one injection acts for two days," with repeat dosing every 48 hours as needed. For remote grazing situations where handling frequency is limited, the 20% L.A. may reduce labour—but its meat withdrawal period extends to 28 days (milk: 7 days), compared with 12 days (meat) and 5 days (milk) for the 10% product.

Volume per Injection Site

Because the 10% formulation delivers 100 mg/ml, handlers can achieve the same total milligram dose in a smaller injection volume compared with the 5% product. This directly affects the number of injection sites required, particularly in heavier animals.

Selecting the Right Concentration: Key Decision Criteria

Criterion 1 — Animal Species and Body Size

Confirm the species being treated. If cattle are included in the treatment program, the 5% formulation is not suitable for cattle; both the 10% and 20% L.A. products cover cattle. For lighter small ruminants or swine where a lower per-injection milligram load is preferred, the 5% formulation may be considered, subject to a vet's guidance.

Criterion 2 — Treatment Duration and Handling Frequency

If animals can be restrained daily for 3–5 days, the 10% formulation provides a standard short-course protocol. If daily handling is impractical, the 20% L.A. option (every-48-hour dosing) reduces the number of interventions. Procurement teams should confirm which protocol their operation's infrastructure supports before ordering.

Criterion 3 — Withdrawal Period Constraints

Operations with short intervals between treatment and slaughter or milk collection must account for withdrawal times. The 10% formulation's 12-day meat withdrawal and 5-day milk withdrawal are shorter than the 20% L.A. product's 28-day meat and 7-day milk periods. Where fast throughput is required, the 10% formulation may be more compatible with production schedules.

Criterion 4 — Injection Site Volume Management

In heavier full-grown cattle, calculated doses can be large. The 10% product's per-site maximum is 20 ml for cattle. Buyers should verify that calculated total dose volumes are distributable across acceptable injection sites before committing to a formulation strength.

Criterion 5 — Drug Interaction and Contraindication Screening

All three oxytetracycline formulations share the same contraindication profile (tetracycline hypersensitivity, renal/liver impairment, incompatible antibiotics). Buyers managing mixed medication programs must screen for concurrent use of penicillins, cephalosporins, quinolones, or cycloserine across the herd before selecting any oxytetracycline product.

Procurement Considerations

The following factors should be verified with the supplier before finalising an order, as they are not specified in the confirmed product materials:

• Available pack sizes — the product excerpt references 100 ml bottles in the source SEO context only; buyers should confirm current offerings directly.
• Shelf life and cold-chain requirements — consult the supplier for storage and handling specifications.

For enquiries, contact Shijiazhuang Roc Cattle I&E Trading Co.,Ltd directly through the website.

Summary

Oxytetracycline 10 injection delivers 100 mg of active ingredient per millilitre and is confirmed for intramuscular or subcutaneous treatment of arthritis, respiratory, and gastrointestinal infections in calves, cattle, goats, sheep, and swine. Its 12-day meat and 5-day milk withdrawal periods are shorter than those of the 20% L.A. formulation, making it practical for operations with faster production cycles. It covers cattle—unlike the 5% formulation—and requires daily dosing, in contrast to the every-48-hour schedule of the long-acting 20% product. Matching the concentration to species, handling capacity, and withdrawal requirements is the core purchasing decision.